Trials / Withdrawn
WithdrawnNCT02009124
Stem Cell Therapy in Spinal Cord Injury
Open Label Study of Autologous Bone Marrow Mononuclear Cells in Spinal Cord Injury
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Neurogen Brain and Spine Institute · Academic / Other
- Sex
- All
- Age
- 12 Months – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to study the effect of stem cell therapy on common symptoms in patients with spinal cord injury.
Detailed description
Autologous bone marrow mononuclear cells are administered intrathecally by a standard procedure followed by vigorous rehabilitation therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Autologous bone marrow mononuclear cell transplantation | Bone marrow is aspirated by a standard procedure. Mononuclear cells are separated by density gradient method and then injected intrathecally by a standard lumbar puncture procedure |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2018-06-01
- Completion
- 2018-12-01
- First posted
- 2013-12-11
- Last updated
- 2018-10-25
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT02009124. Inclusion in this directory is not an endorsement.